Terms: = Uterine cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Treatment
3 results:
1. A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening.
Cao L; Yang J; Rong Z; Li L; Xia B; You C; Lou G; Jiang L; Du C; Meng H; Wang W; Wang M; Li K; Hou Y
Med Image Anal; 2021 Oct; 73():102197. PubMed ID: 34403932
[TBL] [Abstract] [Full Text] [Related]
2. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.
Engerud H; Hope K; Berg HF; Fasmer KE; Tangen IL; Haldorsen IS; Trovik J; Krakstad C
PLoS One; 2019; 14(1):e0210585. PubMed ID: 30645608
[TBL] [Abstract] [Full Text] [Related]
3. A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature.
Hasegawa K; Ichikawa R; Ishii R; Oe S; Kato R; Kobayashi Y; Kuroda M; Udagawa Y
Int J Clin Oncol; 2011 Dec; 16(6):751-8. PubMed ID: 21519815
[TBL] [Abstract] [Full Text] [Related]
